Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18258425rdf:typepubmed:Citationlld:pubmed
pubmed-article:18258425lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:18258425lifeskim:mentionsumls-concept:C0006118lld:lifeskim
pubmed-article:18258425lifeskim:mentionsumls-concept:C0002520lld:lifeskim
pubmed-article:18258425lifeskim:mentionsumls-concept:C0001128lld:lifeskim
pubmed-article:18258425lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:18258425lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:18258425lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:18258425lifeskim:mentionsumls-concept:C0040399lld:lifeskim
pubmed-article:18258425lifeskim:mentionsumls-concept:C1708632lld:lifeskim
pubmed-article:18258425lifeskim:mentionsumls-concept:C1512628lld:lifeskim
pubmed-article:18258425lifeskim:mentionsumls-concept:C1522485lld:lifeskim
pubmed-article:18258425lifeskim:mentionsumls-concept:C2353562lld:lifeskim
pubmed-article:18258425pubmed:issue4lld:pubmed
pubmed-article:18258425pubmed:dateCreated2008-2-18lld:pubmed
pubmed-article:18258425pubmed:abstractTextsyn- and anti-1-amino-3-[2-iodoethenyl]-cyclobutane-1-carboxylic acid (syn-, anti-IVACBC 16, 17) and their analogue 1-amino-3-iodomethylene-cyclobutane-1-carboxylic acid (gem-IVACBC 18) were synthesized and radioiodoinated with [(123)I] in 34-43% delay-corrected yield. All these amino acids entered 9L gliosarcoma cells primarily via L-type transport in vitro with high uptake of 8-10% ID/1 x 10(6) cells. Biodistribution studies of [(123)I]16, 17 and 18 in rats with 9L gliosarcoma brain tumors demonstrated high tumor to brain ratios (4.7-7.3:1 at 60 min post-injection). In this model, syn-, anti-, and gem-[(123)I]IVACBC are promising radiotracers for SPECT brain tumor imaging.lld:pubmed
pubmed-article:18258425pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18258425pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18258425pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18258425pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18258425pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18258425pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18258425pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18258425pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18258425pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18258425pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18258425pubmed:languageenglld:pubmed
pubmed-article:18258425pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18258425pubmed:citationSubsetIMlld:pubmed
pubmed-article:18258425pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18258425pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18258425pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18258425pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18258425pubmed:statusMEDLINElld:pubmed
pubmed-article:18258425pubmed:monthFeblld:pubmed
pubmed-article:18258425pubmed:issn1464-3405lld:pubmed
pubmed-article:18258425pubmed:authorpubmed-author:OlsonJeffrey...lld:pubmed
pubmed-article:18258425pubmed:authorpubmed-author:YuWeipingWlld:pubmed
pubmed-article:18258425pubmed:authorpubmed-author:GoodmanMark...lld:pubmed
pubmed-article:18258425pubmed:authorpubmed-author:CampVernon...lld:pubmed
pubmed-article:18258425pubmed:authorpubmed-author:WilliamsLarry...lld:pubmed
pubmed-article:18258425pubmed:authorpubmed-author:MalveauxEugen...lld:pubmed
pubmed-article:18258425pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18258425pubmed:day15lld:pubmed
pubmed-article:18258425pubmed:volume18lld:pubmed
pubmed-article:18258425pubmed:ownerNLMlld:pubmed
pubmed-article:18258425pubmed:authorsCompleteYlld:pubmed
pubmed-article:18258425pubmed:pagination1264-8lld:pubmed
pubmed-article:18258425pubmed:dateRevised2011-5-20lld:pubmed
pubmed-article:18258425pubmed:meshHeadingpubmed-meshheading:18258425...lld:pubmed
pubmed-article:18258425pubmed:meshHeadingpubmed-meshheading:18258425...lld:pubmed
pubmed-article:18258425pubmed:meshHeadingpubmed-meshheading:18258425...lld:pubmed
pubmed-article:18258425pubmed:meshHeadingpubmed-meshheading:18258425...lld:pubmed
pubmed-article:18258425pubmed:meshHeadingpubmed-meshheading:18258425...lld:pubmed
pubmed-article:18258425pubmed:meshHeadingpubmed-meshheading:18258425...lld:pubmed
pubmed-article:18258425pubmed:meshHeadingpubmed-meshheading:18258425...lld:pubmed
pubmed-article:18258425pubmed:meshHeadingpubmed-meshheading:18258425...lld:pubmed
pubmed-article:18258425pubmed:meshHeadingpubmed-meshheading:18258425...lld:pubmed
pubmed-article:18258425pubmed:meshHeadingpubmed-meshheading:18258425...lld:pubmed
pubmed-article:18258425pubmed:meshHeadingpubmed-meshheading:18258425...lld:pubmed
pubmed-article:18258425pubmed:meshHeadingpubmed-meshheading:18258425...lld:pubmed
pubmed-article:18258425pubmed:meshHeadingpubmed-meshheading:18258425...lld:pubmed
pubmed-article:18258425pubmed:year2008lld:pubmed
pubmed-article:18258425pubmed:articleTitleSynthesis and evaluation of [123I] labeled iodovinyl amino acids syn-, anti-1-amino-3-[2-iodoethenyl]-cyclobutane-1-carboxylic acid, and 1-amino-3-iodomethylene-cyclobutane-1-carboxylic acid as potential SPECT brain tumor imaging agents.lld:pubmed
pubmed-article:18258425pubmed:affiliationDepartment of Radiology, Emory University, School of Medicine, Atlanta, GA 30322, USA.lld:pubmed
pubmed-article:18258425pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18258425pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:18258425lld:chembl